ViroPharma Drops After Marrow Transplant Drug Flops in Study - Bloomberg PDF Print

9 (Bloomberg) -- ViroPharma Inc. lost more than half its value in Nasdaq trading after its experimental drug for bone marrow transplant patients failed in ...

read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.